Table 3. Overall survival (OS) and progression-free survival (PFS) rates.
OS rate (%) | PFS rate (%) | ||||||||
---|---|---|---|---|---|---|---|---|---|
1-year | 3-year | 5-year | P | 1-year | 3-year | 5-year | P | ||
Region | Group 1 | 83.5 | 58.1 | 42.2 | 0.554 | 73.6 | 46.5 | 31.6 | 0.614 |
Group 2 | 79.7 | 49.5 | 40.4 | 71.4 | 32.4 | 30.6 |
Group 1: decreased methylation level of tumor relative to the cut-off (70.3%)
Group 2: elevated methylation level of tumor relative to the cut-off (70.3%)